Last updated on June 2019

Study to Assess the Efficacy and Safety of ACT-541468 in Adult and Elderly Subjects Suffering From Difficulties to Sleep


Brief description of study

The main purpose of this Phase 3 study is to evaluate the efficacy of 10 mg and 25 mg ACT-541468 on objective sleep parameters in subjects with insomnia disorder.

Clinical Study Identifier: NCT03575104

Find a site near you

Start Over

Aventiv Research Inc.

Columbus, OH United States
  Connect »

Pulmonary Associates, Pa

Glendale, AZ United States
  Connect »

Core Healthcare Group

Cerritos, CA United States
  Connect »

Pacific Research Network

San Diego, CA United States
  Connect »

Santa Monica Clinical Trials

Santa Monica, CA United States
  Connect »

Empire Clinical Research

Upland, CA United States
  Connect »

Innovative Clinical Research

Lafayette, CO United States
  Connect »

Clinical Research of South Florida

Coral Gables, FL United States
  Connect »

Clinical Trials Research

Lincoln, FL United States
  Connect »

Sleep Practitioners, LLC

Macon, GA United States
  Connect »

Rowe Neurology Institute

Lenexa, KS United States
  Connect »

Neurocare Inc.

Newton, MA United States
  Connect »

Precise Research Centers

Flowood, MS United States
  Connect »

Wake Research Associates

Raleigh, NC United States
  Connect »

Clinical Trials of America - NC, LLC

Winston-Salem, NC United States
  Connect »

CTI Clinical Research II

Cincinnati, OH United States
  Connect »

Cleveland Sleep Research Center

Middleburg Heights, OH United States
  Connect »

Robert V. Sibilia, MD, Inc.

Wooster, OH United States
  Connect »

InSite Clinical Research

DeSoto, TX United States
  Connect »

Noble Clinical Research

Tucson, AZ United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.